Find

Department of Clinical Medicine

Medical/Steno Aarhus Research Laboratory

Publications

Search for a publication

List of publications

Sort by: Date | Author | Title

van Hulten, V., Souverein, P. C., Starup-Linde, J., Viggers, R., Klungel, O. H., Vestergaard, P., Brouwers, M. C. J. G., van den Bergh, J. P. & Driessen, J. H. M. (2024). The association of type 2 diabetes-related characteristics with fracture risk at different sites. Diabetes, Obesity and Metabolism, 26(11), 4887-4896. https://doi.org/10.1111/dom.15884

Veedfald , T., Hjelholt, T. J., Frølich, A., Appel, C. W., Thomsen, H. H., Prior, A., Bjerrum, A. D., Balsby, M., Jensen, A. M. S. & Nielsen, L. K. (2024). Association of the Tillburg Frailty Indicator with mortality, readmission, and healthcare contacts in adult patients with multimorbidity. European Geriatric Medicine, 15(suppl 1), 248. https://doi.org/10.1007/s41999-024-01090-y

Vernstrøm, L., Gullaksen, S., Sørensen, S. S., Ringgaard, S., Laustsen, C., Birn, H., Funck, K. L., Laugesen, E. & Poulsen, P. L. (2024). Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial. Diabetologia, 67(10), 2175-2187. https://doi.org/10.1007/s00125-024-06228-y

Vernstrøm, L., Gullaksen, S., Sørensen, S. S., Funck, K. L., Laugesen, E. & Poulsen, P. L. (2024). Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32-week randomized trial. Diabetes, Obesity and Metabolism, 26(5), 1624-1635. https://doi.org/10.1111/dom.15464

Vestergaard, S. V., Trolle, C., Meegard, L. H. V., Krogh, M. L. & Sædder, E. A. (2024). Medicintilskudssystemet og utilgængelige data gør regioner magtesløse. Ugeskrift for Læger, 186(2), 176-177.

Vigh-Larsen, JF., Kruse, DZ., Moseholt, MB., Hansen, LG. B., Christensen, A. LL., Bæk, A., Andersen, OE., Mohr, M. & Overgaard, K. (2024). No Effects of Carbohydrate Ingestion on Muscle Metabolism or Performance During Short-Duration High-Intensity Intermittent Exercise. Scandinavian Journal of Medicine & Science in Sports, 34(9), Article e14731. https://doi.org/10.1111/sms.14731

Villumsen, B., Frystyk, J., Jørgensen, M. G., Hørdam, B. & Borre, M. (2024). Exergaming Improves Cardiac Risk Factors in Prostate Cancer Patients: A Single-Blinded Randomized Controlled Trial. Games for Health, 13(2), 93-99. https://doi.org/10.1089/g4h.2023.0096

Voigt, J. H., Lauritsen, K. M., Pedersen, S. B., Hansen, T. K., Møller, N., Jessen, N., Laurenti, M. C., Dalla Man, C., Vella, A., Gormsen, L. C. & Søndergaard, E. (2024). Four weeks SGLT2 inhibition improves beta cell function and glucose tolerance without affecting muscle free fatty acid or glucose uptake in subjects with type 2 diabetes. Basic & Clinical Pharmacology & Toxicology, 134(5), 643-656. https://doi.org/10.1111/bcpt.13991

von Koch, S., Koul, S., Grimfjärd, P., Andersson, J., Jernberg, T., Omerovic, E., Fröbert, O., Erlinge, D. & Mohammad, M. A. (2024). Percutaneous coronary intervention plus medical therapy versus medical therapy alone in chronic coronary syndrome: a propensity score-matched analysis from the Swedish Coronary Angiography and Angioplasty Registry. Heart, 110(22), 1307-1315. https://doi.org/10.1136/heartjnl-2024-324307

Wang, Q. J., Costa Correa, C. M., Andersen, S. K., Birkle, P. & Jeppesen, P. B. (2024). Metabolic effects of colour- and odour-induced sweetness enhancement. Food Quality and Preference, 113, Article 105056. https://doi.org/10.1016/j.foodqual.2023.105056

Displaying results 691 to 700 out of 4018

70

Revised 11.09.2025

-

Department of Clinical Medicine